|
|
| Ind-Swift Laboratories Limited |
|
Financials-Ind-Swift Laboratories Limited| Sector: Bulk Drugs | | BSE:532305 | NSE:INDSWFTLAB | Bloomberg:ISL@IN | Reuters:ISLB.BO | | Market Lot: 1 | Face Value: 10 | ISIN Demat: INE915B01019 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2021(3) |
31-Mar-2020(3) |
% Change |
| Sales of Products/Services |
2178.42 |
1850.39 |
17.73 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
25.63 |
118.61 |
-78.39 |
| Total Income |
2204.05 |
1969.00 |
11.94 |
| Total Expenses |
-2289.03 |
-1928.84 |
18.67 |
| OPBDIT |
4493.08 |
3897.84 |
15.27 |
| Interest |
0.00 |
0.00 |
-- |
| Depreciation |
-279.30 |
-1928.84 |
-85.52 |
| Exceptional & Extraordinary Items |
0.00 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
-205.15 |
-8.22 |
2395.74 |
| After Tax Profit |
-290.14 |
31.95 |
NM |
| Equity Capital |
0.00 |
0.00 |
-- |
| Reserves |
0.00 |
0.00 |
-- |
| Notes to Accounts |
|
|
|
|
| As on( Months ) |
31-Mar-07(12) |
|
31-Mar-06(12) |
|
31-Mar-05(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
3437.50 |
99.75 |
3140.93 |
99.96 |
2213.84 |
95.39 |
| Operating Income (OI) |
3446.19 |
100.00 |
3142.07 |
100.00 |
2320.78 |
100.00 |
| OPBDIT |
712.28 |
20.67 |
650.44 |
20.70 |
456.42 |
19.67 |
| OPBDT |
453.52 |
13.16 |
527.13 |
16.78 |
374.23 |
16.13 |
| OPBT |
243.57 |
7.07 |
409.20 |
13.02 |
318.17 |
13.71 |
| Non-Operating Income |
13.11 |
0.38 |
3.84 |
0.12 |
1.16 |
0.05 |
| Extraordinary/Prior Period |
-29.63 |
-0.86 |
-28.42 |
-0.90 |
-28.51 |
-1.23 |
| Tax |
33.41 |
0.97 |
36.75 |
1.17 |
26.03 |
1.12 |
| Profit after tax(PAT) |
193.64 |
5.62 |
347.87 |
11.07 |
264.80 |
11.41 |
| Cash Profit |
403.60 |
11.71 |
465.79 |
14.82 |
320.86 |
13.83 |
| Dividend-Equity |
26.72 |
0.78 |
33.18 |
1.06 |
24.52 |
1.06 |
|
| As on |
31-Mar-07 |
|
31-Mar-06 |
|
31-Mar-05 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
2852.11 |
52.17 |
2052.23 |
43.76 |
1020.87 |
33.58 |
| Net Block |
2570.63 |
47.02 |
1835.73 |
39.15 |
872.10 |
28.69 |
| Capital WIP |
210.33 |
3.85 |
479.15 |
10.22 |
593.48 |
19.52 |
| Investments |
226.46 |
4.14 |
173.99 |
3.71 |
31.42 |
1.03 |
| Inventory |
874.61 |
16.00 |
826.46 |
17.62 |
694.71 |
22.85 |
| Receivables |
837.19 |
15.31 |
666.30 |
14.21 |
485.07 |
15.96 |
| Other Current Assets |
748.02 |
13.68 |
707.76 |
15.09 |
363.46 |
11.95 |
| Balance Sheet Total(BT) |
5467.23 |
100.00 |
4689.38 |
100.00 |
3040.25 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
228.36 |
4.18 |
215.20 |
4.59 |
184.00 |
6.05 |
| Reserves |
1361.01 |
24.89 |
1209.13 |
25.78 |
706.14 |
23.23 |
| Total Debt |
2912.77 |
53.28 |
2254.79 |
48.08 |
1488.46 |
48.96 |
| Creditors and Acceptances |
640.12 |
11.71 |
565.01 |
12.05 |
457.67 |
15.05 |
| Other current liab/prov. |
324.97 |
5.94 |
445.26 |
9.49 |
203.97 |
6.71 |
| Balance Sheet Total(BT) |
5467.23 |
100.00 |
4689.38 |
100.00 |
3040.25 |
100.00 |
|
| As on |
31-Mar-07 |
31-Mar-06 |
31-Mar-05 |
| OPBIT/Prod.cap.empl.(%) |
12.36 |
17.60 |
22.83 |
| PBIT/Cap. Employed (%) |
11.32 |
15.87 |
20.90 |
| PAT/Networth (%) |
12.18 |
24.42 |
29.75 |
| Tax/PBT (%) |
14.71 |
9.56 |
8.95 |
| Total Debt/Networth (x) |
1.83 |
1.58 |
1.67 |
| Long Term Debt/Networth (x) |
1.32 |
1.15 |
1.21 |
| PBDIT/Finance Charges (x) |
2.69 |
5.08 |
5.22 |
| Current Ratio (x) |
2.55 |
2.18 |
2.33 |
| RM Inventory (days consumption) |
123.07 |
123.91 |
142.06 |
| FG inventory (days cost of sales) |
7.36 |
7.82 |
10.73 |
| Receivables (days gross sales) |
85.81 |
75.20 |
77.30 |
| Creditors (days cost of sales) |
85.46 |
82.77 |
89.60 |
| Op. curr. assets (days OI) |
261.00 |
234.00 |
240.00 |
|
|
Financials